ATE471155T1 - Neues impfstoffadjuvans und dessen herstellung und verwendung - Google Patents

Neues impfstoffadjuvans und dessen herstellung und verwendung

Info

Publication number
ATE471155T1
ATE471155T1 AT05733210T AT05733210T ATE471155T1 AT E471155 T1 ATE471155 T1 AT E471155T1 AT 05733210 T AT05733210 T AT 05733210T AT 05733210 T AT05733210 T AT 05733210T AT E471155 T1 ATE471155 T1 AT E471155T1
Authority
AT
Austria
Prior art keywords
production
vaccine adjuvant
new vaccine
present
skin extract
Prior art date
Application number
AT05733210T
Other languages
English (en)
Inventor
Larry Mcdougald
Alberta Fuller
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Application granted granted Critical
Publication of ATE471155T1 publication Critical patent/ATE471155T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seeds, Soups, And Other Foods (AREA)
AT05733210T 2004-03-12 2005-03-14 Neues impfstoffadjuvans und dessen herstellung und verwendung ATE471155T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55263604P 2004-03-12 2004-03-12
PCT/US2005/008400 WO2005089262A2 (en) 2004-03-12 2005-03-14 Novel peanut skin extract as a vaccine adjuvant

Publications (1)

Publication Number Publication Date
ATE471155T1 true ATE471155T1 (de) 2010-07-15

Family

ID=34994226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05733210T ATE471155T1 (de) 2004-03-12 2005-03-14 Neues impfstoffadjuvans und dessen herstellung und verwendung

Country Status (6)

Country Link
EP (1) EP1742656B1 (de)
AT (1) ATE471155T1 (de)
CA (1) CA2559272C (de)
DE (1) DE602005021873D1 (de)
DK (1) DK1742656T3 (de)
WO (1) WO2005089262A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879342B2 (en) * 2004-03-12 2011-02-01 Univ. Of Georgia Research Foundation, Inc. Vaccine adjuvant and making and using the same
US9050281B2 (en) 2008-05-29 2015-06-09 Intervet Inc. Coccidiosis vaccines
EP2355844A2 (de) 2008-11-13 2011-08-17 Intervet International BV Truthahn-eimeria-vakzine

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5279960A (en) 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
EP0256878B1 (de) 1986-08-18 1993-04-14 Btg International Limited Impfstoffe
US4808404A (en) 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA894726B (en) 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
US5068104A (en) 1988-08-01 1991-11-26 A. H. Robins Company Incorporated Live vaccine for coccidiosis utilizing coccidial sporozoites
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
ZA902147B (en) 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
ES2059711T3 (es) 1989-06-21 1994-11-16 Akzo Nv Metodo para la preparacion de una secuencia de acido nucleico codificante de un polipeptido de eimeria tenella.
DK0575317T3 (da) 1991-03-14 1996-12-09 British Tech Group Usa Rekombinant anticoccidie-vaccine
ZA924203B (en) 1991-06-18 1993-03-31 Akzo Nv Coccidiosis poultry vaccine
WO1993001276A1 (en) 1991-07-12 1993-01-21 Smithkline Beecham Corporation Continuous cell line and vaccine against avian coccidia
DE69432137T2 (de) 1993-11-12 2003-11-06 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff gegen Geflügelkokzidose
NZ272945A (en) 1994-09-16 1997-12-19 Akzo Nobel Nv Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
US6777005B1 (en) 1994-10-03 2004-08-17 Mars, Incorporated Foods containing a cocoa polyphenol additive
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
US5566064A (en) 1995-05-26 1996-10-15 Apple Computer, Inc. High efficiency supply for electroluminescent panels
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US6696485B1 (en) 1996-04-02 2004-02-24 Mars, Incorporated Procyanidin and cyclo-oxygenase modulator compositions
US6469053B1 (en) 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US6207842B1 (en) 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6805883B2 (en) 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6156912A (en) 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
US6476241B1 (en) 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
US6908620B2 (en) 2002-12-09 2005-06-21 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same

Also Published As

Publication number Publication date
WO2005089262A3 (en) 2006-10-12
CA2559272A1 (en) 2005-09-29
WO2005089262A2 (en) 2005-09-29
CA2559272C (en) 2015-12-01
DK1742656T3 (da) 2010-07-19
EP1742656B1 (de) 2010-06-16
EP1742656A4 (de) 2007-11-14
EP1742656A2 (de) 2007-01-17
DE602005021873D1 (de) 2010-07-29

Similar Documents

Publication Publication Date Title
PH12014501835A1 (en) Novel adjuvant compositions
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
IN2014DN08830A (de)
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
UA99659C2 (uk) Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
WO2005087238A3 (en) Method for stimulating the immune, inflammatory or neuroprotective response
IN2012DN02736A (de)
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
CA2763359C (en) New human rotavirus strains and vaccines
GB2386072A (en) Novel vaccine
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
EP1471936A4 (de) Hiv-vakzine und anwendungsverfahren
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
ATE471155T1 (de) Neues impfstoffadjuvans und dessen herstellung und verwendung
NO20045587L (no) Liposom vaksineformulering for finne-fisk
EP4509185A3 (de) Verfahren zur erhöhung der immunogenität von schwach immunogenen antigenspezifischen impfstoffen unter verwendung von oralen hefe-beta-glucanen
WO2007014179A3 (en) Method for controlling immunodominance
BR112012033751A2 (pt) composição de vacina, célula, adjuvante, método de vacinar um paciente contra e. canis e processos para produzir a composição de vacina e o antígeno de e. canis
TN2010000338A1 (en) Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
UA104138C2 (en) Novel adjuvant compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties